| Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376) |
|---|
| 05/18/2006 | US20060105961 Method of using a cox-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasia |
| 05/18/2006 | US20060105412 Phthalein or 9-(o-carboxyphenyl)xanthone compound to which is attached a phenylsulfonyloxy group in which the benzene ring is substituted with an alkyl halide group, a nitro group or a cyano electron-withdrawing group; when the sulfonate bond is cleaved, fluorescein or a derivative is formed |
| 05/18/2006 | US20060104984 Methods and compositions for use in treating cancer |
| 05/17/2006 | EP1657239A2 Chromene compound |
| 05/17/2006 | EP1567530B1 Single pot conversion of artemisinin into arteether |
| 05/17/2006 | EP1345929B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345927B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345926B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345925B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317452B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317447B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | CN1772753A Chinese medicine active compound component for treating senile dementia and its prepn and use |
| 05/17/2006 | CN1256336C Novel 4'-demethyl-4'-0-substituted-1-deoxypodophyllotoxin derivative and geometric isomer thereof, process for preparation thereof and anti-cancer composition comprising same |
| 05/16/2006 | US7045634 Prostamide receptor antagonists |
| 05/11/2006 | US20060100442 Reacting 2-{[(S)-2-methylpent-4-in-1-yl]oxy}-3,4,5,6-tetrahydro-2H-pyrane with acetaldehyde to produce 2RS,6S)-6-Methyl-7-[(RS)-(3,4,5,6-tetrahydro-2H-pyran-2-yl)oxy]hept-3-in-2-ol |
| 05/11/2006 | DE4338348B4 2,6-Disubstituierte Benzotrifluoride 2,6-Disubstituted benzotrifluorides |
| 05/10/2006 | EP1655372A2 Production of polyketides and other natural products |
| 05/10/2006 | EP1655302A2 Antiparasitic artemisinin derivatives (endoperoxides) |
| 05/10/2006 | EP1655294A2 Chromene compound |
| 05/10/2006 | EP1655293A2 Chromene compound |
| 05/10/2006 | EP1654326A1 Triangulenium fluorescent dyes and polymers comprising such dyes |
| 05/10/2006 | EP1653967A2 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia |
| 05/10/2006 | CN1769275A Taxane derivatives and processes for the preparation thereof |
| 05/10/2006 | CN1255410C Fluorinated and alkylated alditol derivatives and polyolefin articles containing same |
| 05/10/2006 | CN1255409C Fluorescent compounds,its preparation method and uses |
| 05/09/2006 | US7041838 (Meth)acrylate esters, starting alcohols for the preparation thereof, processes for preparing both, polymers of the esters, chemically amplifiable resist compositions, and method for forming patterns |
| 05/09/2006 | US7041650 Anticonvulsant derivative salts |
| 05/09/2006 | CA2233666C Heterocyclic fungicides |
| 05/04/2006 | WO2006047204A1 Topiramate analogs |
| 05/04/2006 | WO2006047017A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators |
| 05/04/2006 | WO2006046071A1 Compounds and compositions useful in the treatment of neoplasia |
| 05/04/2006 | WO2006045495A1 Photochromic h-annellated benzo[f]chrome-derivatives |
| 05/04/2006 | WO2006045171A2 Process for obtaining dry steroids derivative from ergostane |
| 05/04/2006 | WO2005118777A3 Novel saccharothrix strain and antibiotics derived therefrom, i.e. mutactimycins and aldgamycins |
| 05/04/2006 | US20060094775 Remedy for corneal ulcer |
| 05/04/2006 | CA2586466A1 Topiramate analogs |
| 05/04/2006 | CA2585847A1 Photochromic h-fused benzo[f]chromene derivatives |
| 05/04/2006 | CA2581223A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators |
| 05/03/2006 | EP1651628A2 Antibiotic compound |
| 05/03/2006 | EP1364040B1 Degradation of epothilones and ethynyl substituted epothilones |
| 05/03/2006 | EP1194404B1 Inhibitors of aspartyl protease |
| 05/03/2006 | CN1768050A Benzopyran compounds useful for treating inflammatory conditions |
| 05/03/2006 | CN1254470C Process for preparation of baccatin III derivatives |
| 05/02/2006 | US7037920 Substituted tricyclic himbacine derivatives that are useful as thrombin receptor antagonists |
| 05/02/2006 | US7037642 Removing compounds from blood products with porous particles immobilized in a matrix |
| 04/27/2006 | WO2006044187A1 A method for preparing acetal-containing compositions and related compositions and articles |
| 04/27/2006 | WO2006043519A1 Cage-shaped cyclobutanoic dianhydrides and process for production thereof |
| 04/27/2006 | US20060089499 Pyrazolopyrimidines and the use thereof for controlling harmful organisms |
| 04/27/2006 | US20060089379 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
| 04/26/2006 | EP1650235A1 Vinyl monomer, polymer derived from such monomer, and a light-emitting device using such polymer |
| 04/26/2006 | EP1650210A1 Therapeutic agent for hyperpotassemia and bone disease |
| 04/26/2006 | EP1650209A1 Griseusin derivatives and their use as antitumor agents |
| 04/26/2006 | EP1650200A1 Sulfonate compound and fluorescent probe using the same |
| 04/26/2006 | EP1648902A1 Substituted furochromenes, preparation thereof and their antiinflammatory action |
| 04/26/2006 | EP1648901A1 Substituted furochromene compounds of antiinflammatory action |
| 04/26/2006 | CN1763209A Comprehensive utilization process for gingko episperm |
| 04/26/2006 | CN1763044A Method for synthesizing olefin type imidacloprid from imidacloprid by microorganism transformation |
| 04/26/2006 | CN1763043A Method for separating gas phase pyromellitic dianhydride from mixed gas |
| 04/26/2006 | CN1253456C Improved process for preparing podophyllotoxin from Chinese podophyllum root |
| 04/25/2006 | US7034035 Having a high residual activity, greater activity at lower application rates, curative activity, and a broader spectrum of efficacy; heterocyclic aromatic amides having a hydroxy group adjacent to the amide functionality |
| 04/25/2006 | US7034015 Interleukin 1 beta and tumour necrosis factor alpha inhibitors |
| 04/20/2006 | WO2006041800A2 5-phenoxyalkoxypsoralens and methods for selective inhibition of the voltage gated kv1.3 potassium channel |
| 04/20/2006 | US20060084819 Total synthesis of myriaporones |
| 04/20/2006 | US20060084698 Methods for preparation and use of psorospermin analogs |
| 04/20/2006 | DE102005045849A1 Preparation of benzocondensed oxyheterocycle, useful in liquid crystalline mixtures, comprises regioselective opening of e.g. oxetane by metallized fluoroaromates and cyclizing the obtained propanol derivative by non-nucleophilic base |
| 04/20/2006 | CA2581859A1 5-phenoxyalkoxypsoralens and methods for selective inhibition of the voltage gated kv1.3 potassium channel |
| 04/19/2006 | EP1647545A1 Antiviral protease inhibitors |
| 04/19/2006 | EP1347983B1 Process for the production of anhydrosugar alcohols |
| 04/19/2006 | EP1120419B1 Derivatives of isosorbid mononitrate, utilization as vasodilator agents with reduced tolerance |
| 04/19/2006 | CN1761669A Preparation of a trans-calanolide ketone intermediate and chiral separation of calanolide alcohols to give racemic calanolide A |
| 04/19/2006 | CN1761667A 3-phenyl substituted 3-substituted-4ketolactams and ketolactones |
| 04/19/2006 | CN1761646A Cannabinoid receptor ligands |
| 04/19/2006 | CN1252073C Process for preparation of garcinia acid |
| 04/18/2006 | CA2273374C Trioxane dimer compounds having antiproliferative and antitumor activities |
| 04/18/2006 | CA2241852C Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon |
| 04/18/2006 | CA2207443C Tricyclic compounds |
| 04/13/2006 | US20060079572 Novel bioactive substance |
| 04/13/2006 | US20060079535 Such as 4-(4-Phenoxybutoxy)-7H-furo[3,2-g][1]benzopyran-7-on; autoimmune diseases |
| 04/13/2006 | US20060078980 Production of polyketides and other natural products |
| 04/12/2006 | EP1644380A2 Biologically active neopeltolide compounds |
| 04/12/2006 | EP1643987A2 Podophyllotoxin derivatives |
| 04/12/2006 | EP1643984A2 Use of parthenolide derivatives as antileukemic and cytotoxic agents |
| 04/12/2006 | EP1005356B1 Novel antibacterial agents |
| 04/12/2006 | CN1759115A Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 04/12/2006 | CN1758905A Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections |
| 04/12/2006 | CN1250552C Prepn process of tripterygium extractive |
| 04/11/2006 | US7026484 For therapy of cancer |
| 04/11/2006 | US7026476 Intermediate arylamine compounds |
| 04/11/2006 | US7026352 Physiologically active substances |
| 04/11/2006 | US7026270 malayamycin A and desmethylmalayamycin A prepared from a previously unknown strain of Streptomyces malaysiensis, used for combating or controlling phytopathogenic fungi |
| 04/11/2006 | CA2281702C (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents |
| 04/11/2006 | CA2155013C C2 taxane derivatives and pharmaceutical compositions containing them |
| 04/06/2006 | WO2006037125A1 Process for preparing forms of atorvastatin calcium substantially free of impurities |
| 04/06/2006 | WO2006036031A1 Fused furan derivative and use thereof |
| 04/06/2006 | WO2006035770A1 Process for synthesis of derivatives, compound library, method for making the mase, and screening method |
| 04/06/2006 | US20060074251 Deoxoartemisinin analogs, process for their preparation, and anticancer agent comprising them |
| 04/06/2006 | CA2581375A1 Specific kinase inhibitors |
| 04/06/2006 | CA2581254A1 Method for synthesizing derivative, compound library and method for constructing the same, and method for screening |
| 04/06/2006 | CA2579997A1 Process for preparing forms of atorvastatin calcium substantially free of impurities |
| 04/05/2006 | EP1642895A2 Novel substituted naphthopyrans |